CAPGEMINI UNS.ADR 1/5/EO8 (F:CGMA) — Stock Price
CAPGEMINI UNS.ADR 1/5/EO8 (F:CGMA) is currently trading at €20.60 EUR, down 4.63% today. Over the past 52 weeks, shares have ranged between €18.70 and €30.80. This page tracks CAPGEMINI UNS.ADR 1/5/EO8's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see CGMA market cap.
CAPGEMINI UNS.ADR 1/5/EO8 (CGMA) Stock Price Chart — Daily History & Trading Volume
The chart below tracks CAPGEMINI UNS.ADR 1/5/EO8's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
CAPGEMINI UNS.ADR 1/5/EO8 Income Statement — Revenue, Profit & Earnings by Year
CAPGEMINI UNS.ADR 1/5/EO8's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | €22.46 Billion | €22.10 Billion | €22.52 Billion | €22.00 Billion |
| Cost of Revenue | €16.39 Billion | €16.04 Billion | €16.47 Billion | €16.16 Billion |
| Gross Profit | €6.08 Billion | €6.05 Billion | €6.05 Billion | €5.83 Billion |
| Research & Development | — | — | — | — |
| SG&A | €3.09 Billion | €3.12 Billion | €3.06 Billion | €2.96 Billion |
| Total Operating Expenses | €19.96 Billion | €19.56 Billion | €19.94 Billion | €19.44 Billion |
| Operating Income | €2.50 Billion | €2.53 Billion | €2.58 Billion | €2.56 Billion |
| EBITDA | — | — | — | — |
| EBIT | — | — | — | — |
| Interest Expense | €198.00 Million | €183.00 Million | €186.00 Million | €157.00 Million |
| Income Before Tax | €2.17 Billion | €2.37 Billion | €2.30 Billion | €2.26 Billion |
| Income Tax Expense | — | — | — | — |
| Net Income | €1.60 Billion | €1.67 Billion | €1.66 Billion | €1.55 Billion |
CAPGEMINI UNS.ADR 1/5/EO8 Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes CAPGEMINI UNS.ADR 1/5/EO8's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Assets | €29.06 Billion | €25.66 Billion | €24.70 Billion | €25.48 Billion |
| Total Current Assets | €9.50 Billion | €9.31 Billion | €9.74 Billion | €10.34 Billion |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | €218.00 Million | €268.00 Million | €161.00 Million | €386.00 Million |
| Net Receivables | €3.26 Billion | €3.24 Billion | €3.29 Billion | €3.33 Billion |
| Inventory | — | — | — | — |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | €14.86 Billion | €12.34 Billion | €11.21 Billion | €11.09 Billion |
| Total Liabilities | €17.39 Billion | €13.86 Billion | €14.23 Billion | €15.74 Billion |
| Total Current Liabilities | €7.86 Billion | €7.71 Billion | €7.25 Billion | €8.06 Billion |
| Long-term Debt | €7.45 Billion | €4.28 Billion | €5.07 Billion | €5.66 Billion |
| Net Debt | €5.52 Billion | €2.35 Billion | €2.21 Billion | €2.96 Billion |
| Total Stockholder Equity | €11.65 Billion | €11.78 Billion | €10.45 Billion | €9.73 Billion |
| Retained Earnings | €7.31 Billion | €7.21 Billion | €5.59 Billion | €4.63 Billion |
CAPGEMINI UNS.ADR 1/5/EO8 Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how CAPGEMINI UNS.ADR 1/5/EO8 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | €2.48 Billion | €2.53 Billion | €2.52 Billion | €2.52 Billion |
| Capital Expenditures | €287.00 Million | €315.00 Million | €259.00 Million | €290.00 Million |
| Free Cash Flow | €2.19 Billion | €2.21 Billion | €2.27 Billion | €2.23 Billion |
| Investing Cash Flow | — | — | — | — |
| Financing Cash Flow | — | — | — | — |
| Dividends Paid | €-581.00 Million | €584.00 Million | €559.00 Million | €409.00 Million |
| Stock-Based Compensation | €266.00 Million | €273.00 Million | €252.00 Million | €164.00 Million |
| Depreciation | €698.00 Million | €683.00 Million | €700.00 Million | €719.00 Million |
| Change in Cash | €269.00 Million | €-827.00 Million | €-163.00 Million | €734.00 Million |
CAPGEMINI UNS.ADR 1/5/EO8 Earnings History — EPS Actual vs. Analyst Estimates
Track CAPGEMINI UNS.ADR 1/5/EO8's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jul 30, 2026 | — | — | — |
| Feb 13, 2026 | — | — | — |
| Jul 30, 2025 | — | — | — |
| May 16, 2025 | — | — | — |
| Feb 18, 2025 | — | — | — |
| Oct 30, 2024 | — | — | — |